- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03267706
Introducing the Palliative Care Comprehensive Tool in Family Medicine
29. august 2017 opdateret af: Ainsley Moore, McMaster University
Introducing the Comprehensive Palliative Care Tool in Family Medicine : A Pilot Randomized Controlled Trial
The purpose of this study is to pilot the introduction of a newly developed palliative care tool to clinicians in a family health team.
The intent of the tool is to improve the quality and comprehensiveness of palliative care, which effects caregiver and patient satisfaction with care received, as well as clinician satisfaction with their delivery of care.
Tool effectiveness will be evaluated by measuring satisfaction scores of caregivers, patients and clinicians who receive training and access to the tool compared to caregivers, patients and clinicians providing usual care (without the tool).
Uptake of the tool and user feedback will be collected
Studieoversigt
Status
Ukendt
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
A newly developed tool to guide clinicians in best palliative care practices was developed based on a combination of published tools and consultation with primary care, end users (clinicians).
The tool will be introduced as a pilot to clinicians who will receive training on use of the tool and access to the tool within a family health team in Ontario, Canada.
The tool will be applied in a controlled study environment that randomly assigns clinicians to one of two groups.
One group will receive training and access to the tool and the other group of clinicians will continue to provide usual care.The tool will be evaluated based on validated satisfaction surveys completed by caregivers, patients and clinicians.
Satisfaction scores of those randomly assigned to care enhanced by the tool will be compared to those receiving usual care at the beginning and end of the study.
Uptake of the tool will be measured, as well as user experience with the tool (feasibility and acceptability)
Undersøgelsestype
Interventionel
Tilmelding (Forventet)
149
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Ontario
-
Hamilton, Ontario, Canada, L8W3J6
- Stonechurch Family Health Centre, Department of Family Medicine McMaster University
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Inclusive sample of all clinicians employed at Stonechurch Family Health Centre
- Inclusive sample of all patients over 18 years of age, registered as palliative within Stonechurch Family Health Centre and who are English speaking
Exclusion Criteria: Patients younger than 18 years of age, patients who are non-English speaking
-
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Palliative Care Comprehensive Tool
Clinicians within the study will be randomly assigned and trained on the use of the Palliative Care Comprehensive Tool
|
Clinicians assigned to the newly developed Palliative Care Comprehensive Tool will be trained during a 1 hour period on the application of the tool; Including rationale for tool development, objective of the tool and demonstration of the tool in action
Andre navne:
|
|
Ingen indgriben: Usual Care
Clinicians within the study will be randomly assigned to usual palliative care (without the newly introduced tool)
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Caregiver satisfaction
Tidsramme: 3 months
|
FAMCARE-2 survey to measure caregiver satisfaction
|
3 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Patient satisfaction
Tidsramme: 3 months
|
FAMCARE-P13
|
3 months
|
|
Clinician satisfaction
Tidsramme: 3 months
|
Physician Satisfaction with Aspects of Chronic Care (modified)
|
3 months
|
|
User feedback
Tidsramme: 3 months
|
Acceptability and feasibility of the Palliative Care Comprehensive Tool will be sought using the Clinical Sensibility Questionnaire
|
3 months
|
|
Uptake of tool
Tidsramme: 3 month
|
Tool implementation will be (rate of tool uptake by clinician)
|
3 month
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Ainsley Moore, MD, Department of Family Medicine McMaster University
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Forventet)
1. september 2017
Primær færdiggørelse (Forventet)
1. marts 2018
Studieafslutning (Forventet)
1. juni 2018
Datoer for studieregistrering
Først indsendt
29. august 2017
Først indsendt, der opfyldte QC-kriterier
29. august 2017
Først opslået (Faktiske)
30. august 2017
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
30. august 2017
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
29. august 2017
Sidst verificeret
1. august 2017
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- PaCCT
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Ingen
IPD-planbeskrivelse
No plan to share data.
Data will be stored on secured facility servers.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Palliativ pleje
-
Xuzhou Medical UniversityIkke rekrutterer endnuIkke-invasiv CAR-T-celleovervågning | BCMA-målrettet PET-skanning | CAR-T-cellebiodistribution og -persistens | GMP-overensstemmende Radiopharmaka-præparation
-
The Affiliated Hospital of Xuzhou Medical UniversityRekrutteringCLL | SLL | CAR-T celleterapiKina
-
Duke UniversityNational Institutes of Health (NIH)RekrutteringHæmatopoietisk stamcelletransplantation | CAR-T celleterapiForenede Stater
-
Azienda Usl di BolognaIRCCS Azienda Ospedaliero-Universitaria di BolognaAfsluttetPalliativ pleje | Palliativ medicin | Hospice og palliativ sygeplejeItalien
-
Stiftung Swiss Tumor InstituteKlinik Hirslanden, Zurich; Palleos Healthcare GmbHRekrutteringPatientrapporterede resultatmål | CAR T-celleterapiSchweiz
-
Patrick C. Johnson, MDRekruttering
-
University Health Network, TorontoIkke rekrutterer endnuLymfom, der modtager CAR-T-terapiCanada
-
The Lymphoma Academic Research OrganisationBristol-Myers Squibb; Novartis; Gilead SciencesRekrutteringHæmatopatologi kvalificeret eller CAR-t-cellebehandlingFrankrig
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRekrutteringCAR-T Terapi KomplikationerItalien
-
University Medical Center GoettingenRekrutteringPalliativ pleje | Palliativ pleje, patientbehandling | Oral sundhedspleje | Oral sundhedsrelateret livskvalitetTyskland
Kliniske forsøg med Palliative Care Comprehensive Tool
-
Beijing BiotechRekrutteringHER2-positiv brystkræft | Triple-negativ brystkræft | Brystkræft (Avanceret/Metastatisk)Kina
-
Beijing BiotechRekrutteringDobbelt-målrettede CAR-NK-celler rettet mod MSLN, EGFR eller HER2 i fremskreden NSCLC (DUO-NK-NSCLC)Ikke-småcellet lungekræft | Avanceret/metastatisk NSCLCKina
-
Beijing BiotechRekrutteringHER2-positiv brystkræft | Triple-negativ brystkræft (TNBC) | Brystkræft (lokalt fremskreden eller metastatisk)Kina